A New Guidebook for Families Facing FSHD Launches on World FSHD Day

Launch of the New Guidebook for Families Facing FSHD

On June 20, 2026, coinciding with World FSHD Day, Cell Healing, represented by Narutaka Nihara, is proud to announce the release of a new guidebook titled "FSHD: The First Book to Read After Diagnosis, Volume 1". This manual is specifically aimed at individuals diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD) and their families. The English version of the book will be available on June 16, 2026, ensuring that the essential information is accessible to a wider audience.

Purpose of the Book

The main goal of this guidebook is to fill the information gap often experienced by those newly diagnosed with FSHD. Many individuals find themselves overwhelmed and confused about where to begin their search for information immediately after diagnosis. This book aims to provide an organized compilation of crucial insights that can help families navigate their new reality with a sense of clarity and hope.

Understanding FSHD

FSHD is a hereditary muscle disease that primarily affects the muscles of the face, shoulder girdle, and upper arms. However, symptoms can vary significantly from one individual to another, impacting other body parts such as the trunk, lower limbs, and even influencing aspects like walking, fatigue, pain, respiratory function, vision, hearing, and daily activities. After diagnosis, both patients and their families must grapple with a plethora of information regarding disease progression, life expectancy, treatment options, genetics, rehabilitation, clinical trials, and lifestyle adjustments.

The challenge lies in the fact that this information is often specialized and fragmented, making it difficult to determine what to understand first and what questions to pose to healthcare providers. "FSHD: The First Book to Read After Diagnosis" distills essential information about FSHD into an easy-to-read introductory format that is particularly useful for individuals newly diagnosed.

Content Overview of Volume 1

Volume 1 of the guidebook covers an array of topics pertinent to understanding FSHD shortly after diagnosis. Key contents include:

- An overview of what FSHD is and its characteristics
- Symptoms affecting the face, shoulder girdle, upper arms, trunk, and lower limbs
- Considerations regarding asymmetry and compensatory movements
- Specific issues for children and those diagnosed with early-onset FSHD
- Information related to breathing, vision, hearing, cardiovascular health, pain, and fatigue
- Diagnostic processes and genetic testing
- Basics of FSHD1, FSHD2, D4Z4, and DUX4
- Severity, evaluation metrics, and disease progression
- Standard care, rehabilitation, assistive devices, and surgical options
- Updates on clinical trials, new drug developments, and DUX4 suppression research
- Genetic counseling and understanding familial implications
- Differences between FSHD and other muscular dystrophies

Additionally, the book includes observational records from Cell Healing that document changes in physical conditions experienced by patients, though these are not clinical trials and do not guarantee specific outcomes.

Future Volumes Planned

This guidebook is the first of a planned trilogy aimed at providing comprehensive resources on FSHD. The upcoming volumes will delve into:

- Volume 2: The mechanisms by which FSHD affects muscle mass, strength, and movement. It will explore the hypotheses of physical effects, anti-inflammatory measures, abnormal protein degradation, and cellular activation, alongside evaluations of recovery, improvement, maintenance, and compensation strategies.
- Volume 3: Documenting real-life treatment processes, home care advice, auxiliary approaches, case studies from the U.S., Malaysia, and Japan, and fostering a correct understanding of necessary hopes amidst misinformation.

Volume 2 is slated for release in late June 2026, while Volume 3 will follow soon after in early July 2026.

Author’s Perspective

“Navigating the sea of information after an FSHD diagnosis can be incredibly daunting,” shares Narutaka Nihara. “Many individuals find that while the information may be medically sound, it can feel stark and impersonal when they are seeking support. My goal for this book is to present crucial facts about FSHD, key symptoms to watch for, standard care protocols, and clinical trial information in a way that is approachable for those newly diagnosed. This is not just about understanding the diagnosis; it’s about fostering a pathway to documenting their journey, understanding their bodies, and facilitating necessary discussions. I hope this guide serves as an entry point toward a more informed future.”

Bibliographic Information

- Title: FSHD: The First Book to Read After Diagnosis, Volume 1
- Author: Narutaka Nihara
- Format: Kindle Edition
- Price: 790 yen
- Release Date: June 17, 2026
- Sales Link: Amazon Japan

English Version: FSHD: The First Book to Read After Diagnosis - Amazon US

Disclaimer

This book serves to provide general medical and health information related to FSHD, lifestyle considerations, and observational records of physical changes. It does not replace professional medical diagnosis, treatment, or advice. Specific concerns regarding symptoms, diagnostics, treatments, medications, rehabilitation, assistive devices, and genetic inquiries should be consulted with qualified healthcare providers. Individual experiences may vary, and the outcomes discussed are not guaranteed. The content herein does not propose to alter or discontinue existing medical, rehabilitation, medication, routine visits, or trial participation.

About the Author

Narutaka Nihara, the representative of Cell Healing, offers treatments for individuals facing challenges with physical functioning and daily activities in Tokyo. Additionally, he publishes books that organize medical information, standard care practices, lifestyle considerations, and observational records of bodily changes in a format that is easy for patients and families to comprehend. Nihara is not a physician, and his works aim to inform rather than replace medical diagnoses or treatments.